Evidence map›Paper›PMID 32843011›Full record

ArticleBMC public health2020

Spatiotemporal characteristics and the epidemiology of tuberculosis in China from 2004 to 2017 by the nationwide surveillance system.

Zhongbao Zuo, Miaochan Wang, Huaizhong Cui, Ying Wang, Jing Wu, Jianjiang Qi, Kenv Pan, Dongming Sui, Pengtao Liu, Aifang Xu

Abstract read
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Tuberculosis incidence in Brazil: time series analysis between 2001 and 2021 and projection until 2030.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhongbao ZuoDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Miaochan WangDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Huaizhong CuiDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Ying WangDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Jing WuDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Jianjiang QiDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Kenv PanDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Dongming SuiDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China.
Pengtao LiuDepartment of General Courses, Weifang Medical University, Weifang, 261053, Shandong Province, China.
Aifang XuDepartment of Clinical Laboratory, Hangzhou Xixi Hospital, 2 Hengbu Road, Xihu District, Hangzhou, 310023, Zhejiang Province, China. 13616500869@163.com.ORCID http://orcid.org/0000-0002-1059-3116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChina has always been one of the countries with the most serious Tuberculosis epidemic in the world. Our study was to observe the Spatial-temporal characteristics and the epidemiology of Tuberculosis in China from 2004 to 2017 with Joinpoint regression analysis, Seasonal Autoregressive integrated moving average (SARIMA) model, geographic cluster, and multivariate time series model.

methodsThe data of TB from January 2004 to December 2017 were obtained from the notifiable infectious disease reporting system supplied by the Chinese Center for Disease Control and Prevention. The incidence trend of TB was observed by the Joinpoint regression analysis. The Seasonal autoregressive integrated moving average (SARIMA) model was used to predict the monthly incidence. Geographic clusters was employed to analyze the spatial autocorrelation. The relative importance component of TB was detected by the multivariate time series model.

resultsWe included 13,991,850 TB cases from January 2004 to December 2017, with a yearly average morbidity of 999,417 cases. The final selected model was the 0 Joinpoint model (P = 0.0001) with an annual average percent change (AAPC) of - 3.3 (95% CI: - 4.3 to - 2.2, P < 0.001). A seasonality was observed across the 14 years, and the seasonal peaks were in January and March every year. The best SARIMA model was (0, 1, 1) X (0, 1, 1)

conclusionIn a word, China still has a high TB incidence. However, the incidence rate of TB was significantly decreasing from 2004 to 2017 in China. Seasonal peaks were in January and March every year. Obvious geographical clusters were observed in Tibet and Xinjiang Province. The relative importance component of TB driving transmission was distinguished from the multivariate time series model. For every provinces over the past 14 years, the autoregressive component played a leading role in the incidence of TB which need us to enhance the early protective implementation.

Indexed as

Population SurveillanceChinaDisease NotificationFemaleForecastingHumansIncidenceMaleRegression AnalysisSpatio-Temporal AnalysisTuberculosisEpidemiologyMultivariate time series modelSpatial-temporalTuberculosis

Identifiers

PMID32843011
PMCPMC7449037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.